HOUSE BILL REPORT
ESHB 2023
This analysis was prepared by non-partisan legislative staff for the use of legislative members in
their deliberations. This analysis is not a part of the legislation nor does it constitute a
statement of legislative intent.
As Passed House:
March 13, 2007
Title: An act relating to newborn screening fees.
Brief Description: Establishing newborn screening fees.
Sponsors: By House Committee on Appropriations (originally sponsored by Representatives Schual-Berke, Hinkle, Cody, Campbell, Darneille, Walsh, Morrell, Seaquist, Hunter, Hunt, Dunshee, Ericks, Haigh, Simpson, Ormsby and Sells).
Brief History:
Appropriations: 2/12/07, 2/19/07 [DPS].
Floor Activity:
Passed House: 3/13/07, 96-0.
Brief Summary of Engrossed Substitute Bill |
|
HOUSE COMMITTEE ON APPROPRIATIONS
Majority Report: The substitute bill be substituted therefor and the substitute bill do pass. Signed by 33 members: Representatives Sommers, Chair; Dunshee, Vice Chair; Alexander, Ranking Minority Member; Bailey, Assistant Ranking Minority Member; Haler, Assistant Ranking Minority Member; Anderson, Buri, Chandler, Cody, Conway, Darneille, Dunn, Ericks, Fromhold, Grant, Haigh, Hunt, Hunter, Kagi, Kenney, Kessler, Kretz, Linville, McDermott, McDonald, McIntire, Morrell, Pettigrew, Priest, Schual-Berke, Seaquist, P. Sullivan and Walsh.
Staff: Bernard Dean (786-7130).
Background:
Newborn infants born in Washington are screened for several inherited genetic disorders
before they are discharged from a hospital. In 2005, screenings were performed for
approximately 78,000 newborns. The Department of Health (DOH) assesses a one-time
charge for the screening, which is added to billings for maternity services. The current fee is
$60.90 per infant. This newborn screening fee does not cover follow-up treatment services
for children.
The DOH is authorized to collect an additional fee to fund specialty clinics that provide
treatment services for hemoglobin diseases, phenylketonuria, congenital adrenal hyperplasia,
congenital hypothyroidism, and, during the 2005-07 fiscal biennium, other inheritable or
metabolic disorders leading to mental retardation or physical defects as defined by the State
Board of Health. The additional fee is currently set at $6.60 per infant. This includes $3.50
per infant to replace discontinued federal grants that supported the treatment of
phenylketonuria and sickle cell disease and $3.10 per infant to help fund the cost of treatment
for children diagnosed with one of five disorders added to the newborn screening panel in
2003. The authority to collect the $3.10 fee expires June 30, 2007.
Summary of Engrossed Substitute Bill:
Newborn screening fees that are used to fund specialty clinics that provide treatment services
for children with heritable or metabolic disorders defined by the State Board of Health are set
at $3.50 per infant in statute.
The list of specific disorders that are eligible to receive treatment funding through newborn
screening fees is removed. Funding for specialty clinics will be used to treat heritable or
metabolic disorders defined by the Senate Board of Health.
Appropriation: None.
Fiscal Note: Available.
Effective Date: The bill takes effect 90 days after adjournment of session in which bill is passed.
Staff Summary of Public Testimony:
(In support) Newborn screening is an important piece of improving the health of our children
in this state. We are working hard to add more disorders to the screening. These screenings
are cost effective. For every dollar spent on screenings, $4.30 comes back. If we don't have
treatment in place, that cost savings is not realized. So, it's important to not just screen the
kids but to also follow up with treatment.
If the fee is ended, it will be devastating to children. There will be fewer services available.
This bill maintains the status quo. Newborn screening profoundly improves the lives of the
families served.
This program works. The University of Washington Medical Center cares for over 500 of the
children affected by the newborn screening. Without the program around 200 children would
be dead, 300 would have mental retardation, and at least 100 of those would be in mental
institutions. That's $10 million in costs per year. The cost of the clinic is around $500,000 a
year. This is a modest request that pays us back.
(Opposed) It's a good idea to screen and identify those with diseases that cause mental
retardation. It is good for them to receive follow up care and it is good to collect a newborn
screening fee from every parent that has a baby. The problem is that it doesn't work that way.
Fifty percent of births get Medicaid and go through Healthy Options. It depends on
negotiations between the Healthy Options plans and the hospitals as to whether or not the fee
gets reimbursed. The fee is largely not reimbursed. We were told by the DSHS that as of
July 1, 2007, the $3.10 would not get reimbursed. Also, private payers also do not
consistently reimburse the fee. The fee doesn't get reimbursed because the fee is not a
service, but a mechanism to raise money for providers.
Persons Testifying: (In support) Representative Schual-Berke, prime sponsor; Cherish Hart,
March of Dimes-Washington; Reynold Scott, University of Washington; Gad B. Kletter,
M.D., Swedish Hospital; and Christine Trahms, Center on Human Development and
Disability, University of Washington.
(Opposed) Len McComb, Washington State Hospital Association.